The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients and uses a host of tools to help mitigate and manage any issues. From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.
The Department shares regular updates about impending and current medicine supply issues directly with the National Health Service and the devolved administrations and communicates with other networks including patient groups where appropriate. These communications include information about mitigation actions and management plans to ensure affected patients can be managed appropriately. The Department does not share this information publicly.